2022 – The Year Of The ADC
Shining a light on ADCs in combination, the next generation of payloads, the use of biomarkers in clinical development, as well as how to evolve manufacturing processes to mitigate supply chain challenges, what ever your interest it'll be covered at World ADC San Diego this September!
Some other NEW sessions that we are excited for this year:
2 brand new seminar days – 1st Next Generation Payloads Day and 1st CQA & Bioanalytical Day – providing a deep dive into the incredibly exciting area of novel and low potency payloads and to address the unique bioanalytical challenges facing ADCs respectively
New Plenary Discussion content – The Industry C-level Panel Discussion will examine recent successes and outline up and coming trends. This session dedicated to showcasing ground breaking combination studies involving best-in-class ADCs, as well as exploring the promise of ADCs targeting Folate Receptor Alpha – we are excited to bring these exciting sessions to life!
More workshops than ever before! With the addition of more workshop sessions for this year bringing the total number to 12, we will take a dive into linker selection, ADCs targeting solid tumors, increasing safety and tolerability through the development process, through to developing design of experiments for quality by design and process optimization – our workshops cater for everyone!
This plus the many other hours of unrivaled content that will be shared really makes this your global one stop shop for antibody drug conjugate from early discovery to late phase manufacturing.
Complete Your 4-day World ADC San Diego Experience
Seminar Days –
Tuesday, September 6th
Introduction to ADCs
Aimed at those new to the field, enjoy this one-day deep dive into the fundamental principles of ADC design and early development.
1st Next-Generation Payloads Seminar Day
This seminar day will showcase structures and early data from immunomodulatory, protein degrader, oligonucleotide and radioconjugate ADCs.
3rd Toxicity Day
Join toxicology experts to help explain, understand and create strategies to mitigate toxicities.
1st CQA & Bioanalytical Day
Learn about the latest technological developments to improve the characterization of your ADC post-administration to better inform clinical strategy and design.
6th ADCs in Combination Day
Gain an insight into combination rationale, benchmark best practices on when and how to combo, and explore beyond ADC and IO combinations, and leave with the toolkit to successfully implement your ADC into a combination trial.
4th CMC Day
Benchmarking regulatory expectations, optimizing relationships with CDMOs, and understanding best practices in scale up are a few of the key themes of this day to enable you to confidently develop your CMC operations to be ready for commercialization.
Scientific Program Days –
Wednesday, September 7th & Thursday, September 8th
With 5 defined streams allowing conversation between like-minded individuals we will provide a comprehensive coverage of the end-to-end development to make this your global one stop shop for all things ADC!
To ensure we are providing your entire team with the insights that they need to advance their own work, we break our agenda into five tracks:
- Process Development
Throughout the day, there will breaks with Structured Networking opportunities to help you build those all important connections and collaborations that have propelled the ADC field forward.
Finish Day One by joining our popular Scientific Poster Session, while joining us at the end of Day Two for the renowned 9th Annual World ADC Awards.
Workshop Day –
Friday, September 9th
Your opportunity to get involved in our intimate discussion working groups to delve into more niche topics.
With a choice of 12 workshops spanning early discovery, through translational and clinical development, and finally on to process development and manufacturing, we have crafted our workshops to ensure that we have something for your entire team!
Take a pick of 12 workshops including:
- Benchmarking How to Approach Linker Selection for Optimal Efficacy
- Increasing Safety & Tolerability of ADCs Through Pre-Clinical & Clinical Development
- Addressing Challenges Associated With the Development of ADCs Targeting Solid Tumors
- Developing Design of Experiments for Quality by Design and Process Optimization
- CMC 101 – An Introduction to ADC CMC
It has been fantastic to see our community grow over the years and continue to advance the development of antibody-drug conjugates, and we look forward to facilitating the progress of forward thinking researchers from the pharmaceutical, biotech and academic institutes once again!